• Exchange: Venture
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

IBEX Technologies Inc

+ Add to Watchlist

IBT:CN

0.0500 CAD 0.0100 16.67%

As of 14:30:28 ET on 12/16/2014.

Snapshot for IBEX Technologies Inc (IBT)

Open: 0.0500 Day's Range: 0.0500 - 0.0500 Volume: 1,240
Previous Close: 0.0600 52wk Range: 0.0400 - 0.0650 1-Yr Rtn: +11.11%

Stock Chart for IBT

No chart data available.
  • IBT:CN 0.0500
  • 1D
  • 1M
  • 1Y
0.0600
Interactive IBT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IBT

Current P/E Ratio (ttm) 1.2500
Estimated P/E(-) -
Relative P/E vs. SPTSX 0.0714
Earnings Per Share (ttm) 0.0400
Est. EPS -
Est. PEG Ratio -
Market Cap (M CAD) 1.24
Shares Outstanding (M) 24.70
30 Day Average Volume 37,995
Price/Book (mrq) 0.4193
Price/Sale (ttm) 0.3871
Dividend Indicated Gross Yield -%
Cash Dividend (CAD) 0.2500
Dividend Ex-Date 01/09/1986
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IBT

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for IBT

IBEX Technologies Inc. develops enzymes for a variety of therapeutic applications such as cardiovascular disease, wound healing and diseases of genetic origin. The Company operates in the United States and Canada.

Paul BaehrChairman/President/CEORichard CollinDir:Finance/Secretary
More Company Profile & Key Executives for IBT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil